Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05329506 · ClinicalTrials.gov registry record
Attitudes and Believes About Vaccinations in a Supportive Care Patient Population
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 104
- Enrollment target
NCT05329506: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT05329506 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05329506 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.
Primary Outcome
We will assess the patient's opinion and perception of the safety of vaccinations based upon a questionnaire and a Likert scale of responses.
Interventions
- OTHER patient population
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2022-03-10 |
| Est. Completion | 2024-07-15 |
What the finished NCT05329506 record still lists
NCT05329506 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which patient population is the first listed.
NCT05329506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05329506 about?
NCT05329506 is a clinical study titled "Attitudes and Believes About Vaccinations in a Supportive Care Patient Population". To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.
What is the current status of trial NCT05329506?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2022-03-10. Estimated completion is 2024-07-15.
What interventions are being tested in trial NCT05329506?
The interventions under investigation include: patient population (OTHER).
Who is sponsoring clinical trial NCT05329506?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI